Indeed, we not only describe an increased RSK activity going along with MAPK signalling hyperactivation, but, for the first time, we also show a direct negative effect of RSK inhibition on the growth of MAPK inhibitor resistant melanoma cells using two different RSK inhibitors. The gene discussed is RPS6KA3; the disease is melanoma.